Jan. 07, 2025 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today ...

StockNews.com assumed coverage on shares of T2 Biosystems (NASDAQ:TTOO – Free Report) in a report released on Tuesday morning. The brokerage issued a sell rating on the medical equipment provider’s ...

Reveal insider sentiment with alternative data that tracks buy and sell trades made by top managers and company directors.

T2 Biosystems (NASDAQ:TTOO) Inc. shares have tumbled to a 52 ... This significant downturn reflects a staggering 1-year change, with the stock value eroding by nearly 95%. According to ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Despite the delisting, T2 Biosystems' common stock is expected to begin trading on the OTC Markets system under the same trading symbol "TTOO" from the suspension date. T2 Biosystems does not plan ...

Research analysts at StockNews.com began coverage on shares of T2 Biosystems (NASDAQ:TTOO – Get Free Report) in a report released on Monday. The brokerage set a “sell” rating on the medical equipment ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

Nasdaq provides visual representation of analyst expected earnings growth. Read our earnings report guide before you consider the forecast information when making investment decisions. Visit the ...

There are no SEC filings that match your filter(s), please update your selections to return more records. Nasdaq provides company’s SEC filings, which are financial statements and reports filed ...